Astronics (ATRO) Q2 2024 earnings summary

Executive summary

• Q2 2024 sales grew 14% year-over-year to $198.1 million, returning to pre-pandemic levels and exceeding guidance, with strong demand and new program wins in both Aerospace and Test Systems segments.

• Net income was $1.5 million, a turnaround from a $12.0 million net loss in Q2 2023, with operating income at $7.6 million.

• Bookings reached $219 million, resulting in a record backlog of $633.4 million and a book-to-bill ratio of 1.11.

• Aerospace, nearly 90% of sales, delivered robust growth and margin gains; Test Systems saw restructuring and a major U.S. Army contract win.

• Operating margin improved due to higher volume and production efficiencies, despite increased legal and incentive expenses.

Financial highlights

• Adjusted EBITDA margin rose to 10.2% from 9.1% last year, with adjusted EBITDA of $20.2 million versus $15.9 million.

• Gross margin increased to 20.9% from 18.7% year-over-year; operating margin improved to 3.8% from 1.4%.

• Q2 net income was $1.5 million ($0.04 per diluted share), compared to a $12.0 million net loss in Q2 2023.

• Bookings reached $219 million (book-to-bill 1.11), backlog hit a record $633.4 million, with $402 million scheduled to ship in H2 2024.

• Cash used in operations was $4.2 million for the first half, mainly due to increased accounts receivable from higher sales.

Outlook and guidance

• Full-year revenue guidance raised to $780–$800 million, a 15% increase over 2023 at the midpoint.

• Q3 revenue forecasted at $195–$205 million, with continued top-line growth expected in Q4.

• Adjusted EBITDA margins in the mid-teens are targeted by year-end, contingent on stable operations and no further one-time charges.

• Capital expenditures for 2024 expected between $17 million and $22 million.

• Cash flow expected to improve significantly in H2 2024.